Hiroko Bando
11PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Mar 19, 2026
Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study.Norikazu Masuda, Hiroyuki Yasojima, Hiroko Bando
|Feb 05, 2026
Venlafaxine reduces hot flashes in hormone receptor-positive breast cancer patients receiving tamoxifen: a prospective single-arm, open-label trial.Riko Sato, Rena Kamohara, Tomohei Matsuo
|Sep 02, 2025
Tumor-expressed GPNMB orchestrates Siglec-9+ TAM polarization and EMT to promote metastasis in triple-negative breast cancer.Thuy Linh Dang Cao, Kunio Kawanishi, Sachie Hashimoto
|Jul 18, 2025
Health-related quality of life and physical activity collected via mobile application and wearable device in patients with HR +/HER2 - advanced breast cancer treated with palbociclib plus endocrine therapy or endocrine therapy alone: 6-month longitudinal study (JBCRG-26).Hiroko Bando, Aya Ueda, Kaori Terata
|May 20, 2024
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks).Toshimi Takano, Norikazu Masuda, Mitsuya Ito
Pageof 2
Frequent Collaborators
4 joint publications
Norikazu Masuda
3 joint publications
Masakazu Toi
3 joint publications
Rikiya Nakamura
2 joint publications
Sachie Hashimoto
2 joint publications
Hiroyuki Yasojima
2 joint publications
Shigenori E Nagai
2 joint publications
Tatsuki R Kataoka
2 joint publications
Tomoyuki Aruga
1 joint publications
Emiko Noguchi
1 joint publications
Hisato Hara
